semaglutide and myasthenia gravis Saxenda Gravis: Safety and Clinical Guidance – Bolt Pharmacy Updated 2025 guidelines for myasthenia

Obesity management: New approaches and pharmacotherapies

The global non-alcoholic beer market alone is forecast at $25.2 billion in 2026

In clinical trials in adult patients for weight reduction, cholelithiasis was reported by 1.6% of Wegovy injection-treated patients and 0.7% of placebo patients

Claims data do not provide information on medication adherence or whether patients took the prescribed medications as directed, which could affect the observed outcomes

The fat loss it produces may be measurable in clinical settings but is unlikely to produce the kind of visible, health-altering transformation that tirzepatide delivers